Ligand Pharmaceuticals Inc (LGND US, +1, 14-May-25)
Todd Davis (CEO since 2022, Non Exec from 2007-2022) purchased $1m of stock on the 9th May at $105.20, increasing his stake by 6%. This is a notable buy from an insider with an excellent record as both a buyer and seller.
This purchase is more than 4x larger than any purchase and follows share price strength. He last bought stock at $97.39 in August 2024, and it’s very encouraging that he’s now making his largest purchase at this higher price.
Octavio Espinoza (CFO since 2022, joined 2016) purchased $156,000 of stock on the same day. This is also a notable trade; it’s his first ever purchase and a reversal from a sale at $116.37 just two months ago (short-swing violation is noted on the form). The company reported earnings on the 8th of May.
We are ranking the stock +1 (strongly positive signal).
If you want the Stock of the Week with insider buying stocks information and analysis in your email, don’t forget to subscribe! Follow us on LinkedIn and Twitter
Check our Signals Performance and if you want to know more about this Signals Service, please, email us at sales_admin@smartinsider.com or fill in the Contact Us form here.
